BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10949716)

  • 1. Is high titre ANA specific for connective tissue disease?
    Vaile JH; Dyke L; Kherani R; Johnston C; Higgins T; Russell AS
    Clin Exp Rheumatol; 2000; 18(4):433-8. PubMed ID: 10949716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases.
    Sulcebe G; Morcka K
    Clin Exp Rheumatol; 1992; 10(3):255-61. PubMed ID: 1582070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic significance of antinuclear antibodies].
    Swaak AJ
    Ned Tijdschr Geneeskd; 2000 Mar; 144(13):585-9. PubMed ID: 10761543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2-4 years' follow-up.
    Al-Allaf AW; Ottewell L; Pullar T
    Clin Rheumatol; 2002 Nov; 21(6):472-7. PubMed ID: 12447630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial antinuclear antibodies titre in pleural and pericardial fluid.
    Wang DY; Yang PC; Yu WL; Kuo SH; Hsu NY
    Eur Respir J; 2000 Jun; 15(6):1106-10. PubMed ID: 10885431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy.
    Dahle C; Skogh T; Aberg AK; Jalal A; Olcén P
    J Autoimmun; 2004 May; 22(3):241-8. PubMed ID: 15041045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseases.
    Davis JM; Moder KG; Homburger HA; Ytterberg SR
    Medicine (Baltimore); 2005 Jul; 84(4):208-217. PubMed ID: 16010205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study.
    Tzaneva S; Volc-Platzer B; Kittler H; Hönigsmann H; Tanew A
    Br J Dermatol; 2008 May; 158(5):1050-4. PubMed ID: 18341657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of antinuclear antibody tests in children.
    McGhee JL; Kickingbird LM; Jarvis JN
    BMC Pediatr; 2004 Jul; 4():13. PubMed ID: 15245579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and specificity of ANA and anti-dsDNA in the diagnosis of systemic lupus erythematosus: a comparison using control sera obtained from healthy individuals and patients with multiple medical problems.
    Wichainun R; Kasitanon N; Wangkaew S; Hongsongkiat S; Sukitawut W; Louthrenoo W
    Asian Pac J Allergy Immunol; 2013 Dec; 31(4):292-8. PubMed ID: 24383972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Speckled antinuclear antibodies in keratinocytes--what does it mean?
    Bukilica MN; Andrejevic SB; Bonaci-Nikolic BM; Nikolic MM
    Clin Exp Rheumatol; 2002; 20(4):499-504. PubMed ID: 12175105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
    Myckatyn SO; Russell AS
    J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between antinuclear antibody data and antibodies against extractable nuclear antigens in a large laboratory cohort.
    Craig WY; Ledue TB
    Clin Chem Lab Med; 2011 Nov; 50(3):497-502. PubMed ID: 22098438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
    Tipu HN; Bashir MM
    J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-dsDNA antibodies in systemic lupus erythematosus: A combination of two quantitative methods and the ANA pattern is the most efficient strategy of detection.
    Almeida González D; Roces Varela A; Marcelino Rodríguez I; González Vera A; Delgado Sánchez M; Aznar Esquivel A; Casañas Rodríguez C; Cabrera de León A
    J Immunol Methods; 2015 Dec; 427():30-5. PubMed ID: 26407840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study.
    Compagno M; Jacobsen S; Rekvig OP; Truedsson L; Heegaard NH; Nossent J; Jönsen A; Jacobsen RS; Eilertsen GØ; Sturfelt G; Bengtsson AA
    Scand J Rheumatol; 2013; 42(4):311-6. PubMed ID: 23496224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of positive antinuclear antibodies in healthy children.
    Wananukul S; Voramethkul W; Kaewopas Y; Hanvivatvong O
    Asian Pac J Allergy Immunol; 2005; 23(2-3):153-7. PubMed ID: 16252846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of anti-SSA/Ro antibody by ELISA, double immunodiffusion, and immunoblotting: a comparative study].
    Tong SQ; Shi Q; Wen XH; Gan XD; Shi YP; Zhao Y; Zeng XF; Zhang FC; Dong Y
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2455-7. PubMed ID: 17156670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence and diagnostic value of antinuclear antibodies without identified antigenic target: a retrospective study of 90 patients].
    Feki S; Frikha F; Ben Hadj Hmida Y; Abed S; Ben Ayed M; Turki H; Hachicha J; Baklouti S; Bahloul Z; Masmoudi H
    Rev Med Interne; 2012 Sep; 33(9):475-81. PubMed ID: 22658165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of screening for antinuclear antibodies by enzyme immunoassay--a preliminary study.
    Divate S; Hardikar P; Bichile LS; Rajadhyaksha A
    J Assoc Physicians India; 2004 Apr; 52():290-3. PubMed ID: 15636329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.